ResMed Inc.
RMD Healthcare Medical Instruments & Supplies
ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.
Follow RMD
ResMed Inc. (RMD) Shares outstanding
ResMed Inc.'s shares outstanding at the end of fiscal 2026 was $146.1M, unchanged from fiscal 2025. Over the past ten years it has ranged from $141.7M (fiscal 2016) to $147.6M (fiscal 2024); the current reading is higher than 58% of that period. ResMed Inc. ranks 13th of 50 Medical Instruments & Supplies companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2026 | $146.1M | (0.87%) |
| FY2025 | $147.3M | (0.14%) |
| FY2024 | $147.6M | 0.06% |
| FY2023 | $147.5M | 0.28% |
| FY2022 | $147.0M | 0.40% |
| FY2021 | $146.5M | 0.55% |
| FY2020 | $145.7M | 0.81% |
| FY2019 | $144.5M | 0.35% |
| FY2018 | $144.0M | 1.08% |
| FY2017 | $142.5M | 0.55% |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Jun 2026 | $146.1M | 0.23% |
| Mar 2026 | $145.7M | (0.44%) |
| Dec 2025 | $146.4M | (0.36%) |
| Sep 2025 | $146.9M | (0.30%) |
| 42 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| MDLN Medline Inc. compare | $861.0M |
| BAX Baxter International Inc. compare | $518.0M |
| ALC Alcon compare | $488.7M |
| BDX Becton, Dickinson and Company compare | $275.2M |
| COO The Cooper Companies, Inc. compare | $193.4M |
| SOLV Solventum Corporation compare | $173.3M |
| RMD ResMed Inc. | $146.1M |
| WST West Pharmaceutical Services, Inc. compare | $71.3M |
| RGEN Repligen Corporation compare | $56.6M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on RMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement